(Q34804834)

English

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study (English)

1 reference

Europe PubMed Central

4 August 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

A M Traish

1

1 reference

Europe PubMed Central

4 August 2017

A Haider

2

1 reference

Europe PubMed Central

4 August 2017

G Doros

3

1 reference

Europe PubMed Central

4 August 2017

F Saad

4

1 reference

Europe PubMed Central

4 August 2017

publication date

15 October 2013

1 reference

Europe PubMed Central

4 August 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

4 August 2017

68

1 reference

Europe PubMed Central

4 August 2017

314-329

1 reference

Europe PubMed Central

4 August 2017

3

1 reference

Europe PubMed Central

4 August 2017

Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Sex steroid hormone levels and body composition in men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone: a vascular hormone in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

The effect of androgens on lipids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone: a metabolic hormone in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Lipid lowering efficacy of atorvastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone and the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Impact of testosterone on body fat composition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Prostate-cancer mortality at 11 years of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Hypogonadism and metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone and cardiovascular disease: an old idea with modern clinical implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone and metabolic syndrome: a meta-analysis study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone concentrations in diabetic and nondiabetic obese men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Androgen deficiency and atherosclerosis: The lipid link

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

The dark side of testosterone deficiency: III. Cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Androgen metabolism in adipose tissue: recent advances.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

The risk of metabolic syndrome according to the high-sensitivity C-reactive protein in apparently healthy Koreans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Sex hormones and hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Gender differences in the regulation of blood pressure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Evaluation of abnormal liver-enzyme results in asymptomatic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Testosterone and regional fat distribution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

8 July 2018

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Aging, androgens, and the metabolic syndrome in a longitudinal study of aging

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Associations of endogenous testosterone and lipid profiles in middle-aged to older Taiwanese men.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Serum testosterone levels and arterial blood pressure in the elderly

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Effects of pravastatin and atorvastatin on HDL cholesterol and glucose metabolism in patients with dyslipidemia and glucose intolerance: the PRAT study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Testosterone treatment and mortality in men with low testosterone levels.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12319

21 January 2018

Testosterone administration suppresses adiponectin levels in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

26 October 2018

Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

26 October 2018

Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

26 October 2018

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

26 October 2018

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

26 October 2018

Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282282

26 October 2018

Goodbye androgen hypothesis, hello saturation model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of sex hormones to lipids and lipoproteins in nondiabetic men

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity, body fat distribution and sex hormones in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous testosterone and serum lipids in middle-aged men

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testosterone and insulin resistance in the metabolic syndrome and T2DM in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24–45 years. The Cardiovascular Risk in Young Finns Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens

1 reference

https://pubmed.ncbi.nlm.nih.gov/24127736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/IJCP.12319

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34804834&oldid=1955571425"